<DOC>
	<DOCNO>NCT01727921</DOCNO>
	<brief_summary>Background : EUS-guided fine needle aspiration ( FNA ) major diagnostic tool patient pancreatic mass high specificity , specificity accuracy . However FNA small needle sometimes failed acquisition tissue due small caliber . To overcome limitation , newly design ProCore needle develop flexible 22 25 gauge ProCore needle frequently use . However comparative study efficacy accuracy 22 25 gauge ProCore needle yet . Aim : To compare efficacy accuracy EUS-guided FNA 22 25 gauge ProCore needle . ( The investigator hypothesize accuracy 25 gauge Procore needle inferior 22 gauge ProCore needle . )</brief_summary>
	<brief_title>Comparative Study 22 25 Gauge ProCore EUS-guided Biopsy Pancreatic Mass</brief_title>
	<detailed_description>Patient method : Patients pancreatic peripancreatic mass image study need pathologic confirm . These patient randomly assign 22 gauge 25 gauge group . Procedure : They undergo EUS-guided FNA , 3 time 10 time to-and pro movement . The number patient require : We use confidence interval ( CIs ) prespecified non-inferiority margin 10 % non-inferiority analysis . We conclude non-inferiority PC25 PC22 low limit 95 % CI difference ( PC25-PC22 ) low -10 % . It assume diagnostic accuracy one pas 75 % three cumulative pass estimate 98.4 % PC22 . Based assumption , calculate sample size 216 sample power 80 % significance level 5 % .</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<criteria>Patients agree participate research 18 year age old patient Patients pancreatic peripancreatic mass image study Contraindication endoscopy Patients young 18 year old Bleeding tendency Cardiopulmonary dysfunction</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>ProCore FNA biopsy</keyword>
</DOC>